Billi Tatum Selected Research

9-((2-phosphonylmethoxy)ethyl)guanine

2/2017	Midterm results from a physician-sponsored investigational device exemption clinical trial evaluating physician-modified endovascular grafts for the treatment of juxtarenal aortic aneurysms.
8/2013	Early report from an investigator-initiated investigational device exemption clinical trial on physician-modified endovascular grafts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Billi Tatum Research Topics

Disease

4	Aortic Aneurysm (Aneurysm, Aortic) 01/2020 - 08/2013
3	Endoleak 04/2019 - 08/2013
2	Aneurysm (Aneurysms) 02/2017 - 08/2013
1	Aortic Diseases 01/2020
1	Renal Artery Obstruction (Renal Artery Stenosis) 01/2020
1	Abdominal Aortic Aneurysm 11/2018
1	Pathologic Constriction (Stenosis) 02/2017
1	Rupture 02/2017

Drug/Important Bio-Agent (IBA)

2	9-((2-phosphonylmethoxy)ethyl)guanineIBA 02/2017 - 08/2013
1	CreatinineIBA 01/2020
1	Contrast MediaIBA 02/2017

Therapy/Procedure

6	Endovascular Aneurysm Repair 01/2020 - 11/2016
2	Length of Stay 02/2017 - 08/2013
1	Stents 02/2017